Article Text

Download PDFPDF

MeVO SAVE technique: initial experience with the 167 cm long NeuroSlider 17 for a combined approach in medium vessel occlusions (MeVOs)
  1. Carlos Pérez-García1,
  2. Santiago Rosati1,
  3. Carlos Gómez-Escalonilla2,
  4. Alfonso López-Frías1,
  5. Juan Arrazola3,
  6. Manuel Moreu1
  1. 1 Interventional Neuroradiology, Hospital Clinico Universitario San Carlos, Madrid, Spain
  2. 2 Neurology, Hospital Clinico Universitario San Carlos, Madrid, Spain
  3. 3 Radiology, Hospital Clinico Universitario San Carlos, Madrid, Spain
  1. Correspondence to Dr Carlos Pérez-García, Interventional Neuroradiology, Hospital Clinico Universitario San Carlos, Madrid, Spain; cperezgarcia.med{at}gmail.com

Abstract

Goyal et al described occlusions in M2/3, A2/3 and P2/3 as medium vessel occlusions (MeVOs); the only available controlled data of mechanical thrombectomy (MT) in MeVOs is limited to the middle cerebral artery M2 segment, suggesting that MT may be effective and safe with high functional independence and recanalization rates. The Stent retriever Assisted Vacuum-locked Extraction (SAVE) technique in mechanical thrombectomy consists of the simultaneous use of a stent retriever and a distal aspiration catheter (DAC), with the removal of both as a unit when performing the thrombectomy pass; however, so far the low-profile (0.035 inch distal inner diameter) DACs were longer (160 cm) than conventional 0.017 inch microcatheters for MeVOs. We present a case of a combined approach MT in MeVO with the use of the new 167 cm long NeuroSlider 17 (Acandis, Pforzheim, Germany) 0.0165 inch microcatheter and 3MAX (Penumbra, Alameda, CA) through the SAVE technique—the MeVO SAVE technique. (video 1).

video 1.
  • stroke
  • intervention
  • technique
  • device
http://creativecommons.org/licenses/by-nc/4.0/

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Statistics from Altmetric.com

Footnotes

  • Twitter @Justcharly9, @manumoreu

  • Contributors Project development: CP-G, MM, JA. Interventional procedure performance: MM, CP-G, SR. Data collection and management: CP-G, CG-E. Video writing/editing: CP-G, MM. Drawings: CP-G. Revising the work critically for important intellectual content: CP-G, MM, SR, CG-E, JA, AL-F. Video final approval: CP-G, MM, SR, CG-E, JA, AL-F. Agreement to be accountable for all aspects of the work: CP-G, MM, SR, CG-E, JA, AL-F.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.